Search results
Novavax seeks EMA approval for updated JN.1 Covid-19 vaccine
Pharmaceutical Technology via Yahoo Finance· 6 hours agoAccording to nonclinical studies, the Novavax JN.1 Covid-19 vaccine elicited a broad neutralising...
COVID summer guide: How to navigate symptoms, variants and vaccines this season amid rising cases
Yahoo Life· 35 minutes agoWho should wait and who should get vaccinated now? The CDC advises that everyone age 5 and older...
Novavax seeks EMA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 1 day agoJacobs, stated that Novavax is working with European markets to provide a protein-based alternative...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 7 days agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 4 days agoNovavax. Last year, Novavax lost $5.41 per share and had $983.7 million in sales. This year, Wall...
COVID is bouncing back this summer. Here’s what to know
Los Angeles Times· 3 hours agoSummer just started, but California’s not-too-surprising seasonal COVID bump is already going...
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 5 days agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
FDA advises vaccine manufacturers to make COVID-19 booster targeting KP.2 strain
ABC Action News Tampa Bay· 1 day agoThe FDA has issued an updated recommendation for the fall COVID-19 vaccine formula. "Coverage in the...
Novavax (NVAX) Ascends While Market Falls: Some Facts to Note
Zacks· 5 days agoFree Report) closed the most recent trading day at $14.06, moving +1.99% from the previous trading session. The stock exceeded the S&P 500, which registered a loss of 0.25% for the day. Heading ...